Dr. Charles Simone, mesothelioma oncologist

Charles B. Simone

Radiation Oncologist

Radiation oncologist Dr. Charles B. Simone is the chief medical officer at the New York Proton Center, the only facility in the state to offer proton radiation therapy for pleural mesothelioma patients.

Get in touch

Content Contributors

Scroll

Written By

Edited By

This page features: 11 cited research articles

About Charles B. Simone

Accolades
  • Team Leader icon

    Team Leader

  • Research Excellence icon

    Excellence in Research

  • Board Certified icon

    Board Certified in Radiation Oncology

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

Simone is known as the leading authority in the use of proton radiation therapies for thoracic malignancies.

He is heavily involved in innovative research and the development of clinical trial strategies with stereotactic body radiation therapy and radiation oncology.

At the New York Proton Center, which is set to open April 2019, he will be working closely with multidisciplinary teams at Mount Sinai Medical Center and Memorial Sloan Kettering Cancer Center.

Both centers previously sent mesothelioma patients out of state if proton therapy was recommended.

Long Career in Maryland

Simone joined the New York Proton Center after serving at the University of Maryland School of Medicine, where he was an associate professor of radiation oncology.

At the UM Greenebaum Cancer Center in Baltimore, Simone was part of a multidisciplinary team that specializes in the diagnosis, treatment and research of mesothelioma and other asbestos-related diseases.

Proton therapy, which is only available at select specialty centers, offers a higher, more precise dose of radiation that eliminates many of the dangerous side effects that often come with traditional radiation.

It reduces the risk to vital organs and nearby tissue, which is especially important for a mesothelioma patient because of the often-vast tumor involvement.

“This is going to be the approach of choice,” Simone said. “We do expect to be busy. This is one of the few centers that can safely treat the entire pleura surface that is often necessary with mesothelioma.”

For years, Simone has been a proponent of patients finding high-volume specialty centers for mesothelioma to receive the best-possible care.

“Going to a high-volume center for oncology makes sense, but particularly for a rare cancer like mesothelioma,” Simone said.

Accomplished Researcher and Author

Simone was the co-author of a recent mesothelioma study that demonstrated how high-volume centers experienced shorter hospital stays, fewer complications and lower three-day readmission rates after surgery than those treated at low-volume centers.

The study, which he published in June of 2018, showed 90-day mortality rates were lower and survival rates higher for those at the high-volume centers.

Before the University of Maryland, Simone worked at the University of Pennsylvania’s Abramson Cancer Center, another high-volume center.

At UPenn, he served as chief of thoracic oncology services and co-director of the Penn Mesothelioma and Pleural Program.

He earned his medical degree from the University of Pennsylvania and did his resident training in radiation oncology at the National Cancer Institute, where he also completed an internship in internal medicine.

Simone used photon and proton radiation therapy in treating patients with various thoracic malignancies at Greenebaum and Abramson.

He has published almost 300 peer-reviewed scientific articles, many of which detail the benefits of proton therapy and its place in a multimodality treatment regimen.

Much of his research is funded by the National Science Foundation, the National Institutes of Health and the Department of Defense.

He also is a member of the National Cancer Institute’s Thoracic Malignancy Steering Committee.

“I look forward to be able to provide patients in New York, the tri-state area and beyond with the very best possible care,” he said.

Disclaimer: Dr. Charles B. Simone has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Get the Best Treatment Options

Find a Doctor
Asbestos.com Mesothelioma Packet

Order Your Free Treatment Guide

Get Yours Now

Find a Mesothelioma Clinical Trial Near You

Get Help Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Matt Mauney, Content Writer at Asbestos.com
Edited by

3 Cited Article Sources

  1. University of Maryland Greenebaum Comprehensive Cancer Center. (n.d.). Meet the Mesothelioma Team.
    Retrieved from: https://www.umms.org/umgccc/cancer-services/cancer-types/mesothelioma/team
  2. University of Maryland School of Medicine. (n.d.). Charles B. Simone, MD.
    Retrieved from: http://www.medschool.umaryland.edu/profiles/Simone-Charles/
  3. University of Maryland Greenebaum Comprehensive Cancer Center. (n.d.). Mesothelioma. Retrieved from: https://www.umms.org/umgccc/cancer-services/cancer-types/mesothelioma
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified March 14, 2019

Get Your Free Mesothelioma Guide Chat live with a patient advocate now